Carfentanil, C-11

DB15360

small molecule investigational

Deskripsi

Carfentanil, C-11 is under investigation in clinical trial NCT01899170 (Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain).

Struktur Molekul 2D

Berat 393.515
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

909 Data
Buprenorphine Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Hydrocodone Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Magnesium sulfate The therapeutic efficacy of Carfentanil, C-11 can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Carfentanil, C-11 may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Mirtazapine Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Orphenadrine Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Pramipexole Carfentanil, C-11 may increase the sedative activities of Pramipexole.
Ropinirole Carfentanil, C-11 may increase the sedative activities of Ropinirole.
Rotigotine Carfentanil, C-11 may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Carfentanil, C-11.
Sodium oxybate Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Thalidomide Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Alvimopan The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Alvimopan.
Desmopressin The risk or severity of hyponatremia can be increased when Carfentanil, C-11 is combined with Desmopressin.
Morphine The risk or severity of adverse effects can be increased when Morphine is combined with Carfentanil, C-11.
Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Carfentanil, C-11.
Hydromorphone The risk or severity of adverse effects can be increased when Hydromorphone is combined with Carfentanil, C-11.
Meperidine The risk or severity of adverse effects can be increased when Meperidine is combined with Carfentanil, C-11.
Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Carfentanil, C-11.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Carfentanil, C-11.
Naltrexone The therapeutic efficacy of Carfentanil, C-11 can be decreased when used in combination with Naltrexone.
Sufentanil The risk or severity of adverse effects can be increased when Sufentanil is combined with Carfentanil, C-11.
Alfentanil The risk or severity of adverse effects can be increased when Alfentanil is combined with Carfentanil, C-11.
Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Carfentanil, C-11.
Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Carfentanil, C-11.
Remifentanil The risk or severity of adverse effects can be increased when Remifentanil is combined with Carfentanil, C-11.
Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Carfentanil, C-11.
Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Carfentanil, C-11.
Dezocine The risk or severity of adverse effects can be increased when Dezocine is combined with Carfentanil, C-11.
Methadyl acetate The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Carfentanil, C-11.
Dihydroetorphine The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Carfentanil, C-11.
Diamorphine The risk or severity of adverse effects can be increased when Diamorphine is combined with Carfentanil, C-11.
Bezitramide The risk or severity of adverse effects can be increased when Bezitramide is combined with Carfentanil, C-11.
Ethylmorphine The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Carfentanil, C-11.
Etorphine The risk or severity of adverse effects can be increased when Etorphine is combined with Carfentanil, C-11.
Dextromoramide The risk or severity of adverse effects can be increased when Dextromoramide is combined with Carfentanil, C-11.
Desomorphine The risk or severity of adverse effects can be increased when Desomorphine is combined with Carfentanil, C-11.
Carfentanil The risk or severity of adverse effects can be increased when Carfentanil is combined with Carfentanil, C-11.
Dihydrocodeine The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Carfentanil, C-11.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Carfentanil, C-11.
Dihydromorphine The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Carfentanil, C-11.
Ketobemidone The risk or severity of adverse effects can be increased when Ketobemidone is combined with Carfentanil, C-11.
DPDPE The risk or severity of adverse effects can be increased when DPDPE is combined with Carfentanil, C-11.
Lofentanil The risk or severity of adverse effects can be increased when Lofentanil is combined with Carfentanil, C-11.
Opium The risk or severity of adverse effects can be increased when Opium is combined with Carfentanil, C-11.
Normethadone The risk or severity of adverse effects can be increased when Normethadone is combined with Carfentanil, C-11.
Piritramide The risk or severity of adverse effects can be increased when Piritramide is combined with Carfentanil, C-11.
Alphaprodine The risk or severity of adverse effects can be increased when Alphaprodine is combined with Carfentanil, C-11.
Nicomorphine The risk or severity of adverse effects can be increased when Nicomorphine is combined with Carfentanil, C-11.
Meptazinol The therapeutic efficacy of Carfentanil, C-11 can be decreased when used in combination with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Phenoperidine is combined with Carfentanil, C-11.
Phenazocine The risk or severity of adverse effects can be increased when Phenazocine is combined with Carfentanil, C-11.
Tilidine The risk or severity of adverse effects can be increased when Tilidine is combined with Carfentanil, C-11.
Naloxegol The risk or severity of adverse effects can be increased when Naloxegol is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Benzhydrocodone.
Pegvisomant The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Carfentanil, C-11.
Succinylcholine The risk or severity of bradycardia can be increased when Succinylcholine is combined with Carfentanil, C-11.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Carfentanil, C-11.
Fluvoxamine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Fluvoxamine.
Sertraline The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Sertraline.
Zimelidine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Zimelidine.
Dapoxetine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Dapoxetine.
Seproxetine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Seproxetine.
Indalpine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Indalpine.
Ritanserin The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Ritanserin.
Alaproclate The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Alaproclate.
Citalopram The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Citalopram.
Duloxetine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Duloxetine.
Trazodone The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Trazodone.
Paroxetine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Paroxetine.
Sibutramine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Sibutramine.
Nefazodone The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Nefazodone.
Escitalopram The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Escitalopram.
Milnacipran The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Milnacipran.
Desvenlafaxine The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Desvenlafaxine.
Ethanol Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Carfentanil, C-11 may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Carfentanil, C-11.
Phentermine Phentermine may increase the analgesic activities of Carfentanil, C-11.
Pseudoephedrine Pseudoephedrine may increase the analgesic activities of Carfentanil, C-11.
Benzphetamine Benzphetamine may increase the analgesic activities of Carfentanil, C-11.
Diethylpropion Diethylpropion may increase the analgesic activities of Carfentanil, C-11.
Lisdexamfetamine Lisdexamfetamine may increase the analgesic activities of Carfentanil, C-11.
Mephentermine Mephentermine may increase the analgesic activities of Carfentanil, C-11.
MMDA MMDA may increase the analgesic activities of Carfentanil, C-11.
Midomafetamine Midomafetamine may increase the analgesic activities of Carfentanil, C-11.
2,5-Dimethoxy-4-ethylamphetamine 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Carfentanil, C-11.
4-Bromo-2,5-dimethoxyamphetamine 4-Bromo-2,5-dimethoxyamphetamine may increase the analgesic activities of Carfentanil, C-11.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul